NCM · Analyst Forecast

60 Degrees Pharmaceuticals, Inc. (SXTP) Analyst Forecast

$0.87 NCM: SXTP Market Cap $3.05M

Revenue and earnings estimates published by analysts covering 60 Degrees Pharmaceuticals, Inc. (SXTP), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For 60 Degrees Pharmaceuticals, Inc., analysts forecast revenue rising from $250.0B in 2023 to $2.00T in 2028; the average estimate for 2028 earnings per share is $-0.60; with published estimates ranging from $-0.67 to $-0.53; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2023	$200.0B	$250.0B	$300.0B	1
2024	$546.5B	$600.0B	$653.5B	1
2025	$1.26T	$1.40T	$1.53T	2
2026	$910.9B	$1.00T	$1.09T	2
2027	$1.15T	$1.40T	$1.65T	2
2028	$1.82T	$2.00T	$2.18T	1

Earnings per share forecast

Year	Low	Average	High	Analysts
2023	$-477.79	$-379.20	$-280.61	1
2024	$-120.15	$-107.68	$-95.21	1
2025	$-12.12	$-11.74	$-11.35	2
2026	$-3.29	$-3.16	$-3.02	2
2027	$-5.99	$-3.58	$-1.17	2
2028	$-0.67	$-0.60	$-0.53	1

60 Degrees Pharmaceuticals, Inc. (SXTP) forecast — frequently asked questions

What are analysts forecasting for 60 Degrees Pharmaceuticals, Inc.'s earnings?

The average analyst estimate for 60 Degrees Pharmaceuticals, Inc. (SXTP) earnings per share in 2028 is -0.60, with individual estimates between -0.67 and -0.53.

How much revenue is 60 Degrees Pharmaceuticals, Inc. expected to make?

Analysts forecast 60 Degrees Pharmaceuticals, Inc. (SXTP) revenue of $2.00T in 2028, based on 1 published estimates.

How many analysts cover SXTP?

2 analysts contribute estimates for 60 Degrees Pharmaceuticals, Inc. (SXTP). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.